N-benzyladriamycin-14-valerate (AD 198) exhibits potent anti-tumor activity on TRAF3-deficient mouse B lymphoma and human multiple myeloma

被引：0
|
作者：
Shanique K E Edwards
Carissa R Moore
Yan Liu
Sukhdeep Grewal
Lori R Covey
Ping Xie
机构：
[1] Rutgers University,Department of Cell Biology and Neuroscience
[2] Rutgers University,Graduate Program in Molecular Biosciences
[3] Rutgers Cancer Institute of New Jersey,undefined
来源：
BMC Cancer | / 13卷
关键词：
AD 198; Non-Hodgkin lymphoma; Multiple myeloma; TRAF3; c-Myc;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 7 条
  • [1] N-benzyladriamycin-14-valerate (AD 198) exhibits potent anti-tumor activity on TRAF3-deficient mouse B lymphoma and human multiple myeloma
    Edwards, Shanique K. E.
    Moore, Carissa R.
    Liu, Yan
    Grewal, Sukhdeep
    Covey, Lori R.
    Xie, Ping
    [J]. BMC CANCER, 2013, 13
  • [2] Aberrant expression of MCC in TRAF3-deficient mouse B lymphoma and human multiple myeloma
    Edwards, Shanique
    Baron, Jacqueline
    Moore, Carissa
    Liu, Yan
    Hart, Ronald
    Xie, Ping
    [J]. JOURNAL OF IMMUNOLOGY, 2012, 188
  • [3] Signaling mechanisms of bortezomib in TRAF3-deficient mouse B lymphoma and human multiple myeloma cells
    Edwards, Shanique K. E.
    Han, Yeming
    Liu, Yingying
    Kreider, Benjamin Z.
    Liu, Yan
    Grewal, Sukhdeep
    Desai, Anand
    Baron, Jacqueline
    Moore, Carissa R.
    Luo, Chang
    Xie, Ping
    [J]. LEUKEMIA RESEARCH, 2016, 41 : 85 - 95
  • [4] N-Benzyladriamycin-14-valerate (AD 198) cytotoxicty circumvents Bcr-Abl anti-apoptotic signaling in human leukemia cells and also potentiates imatinib cytotoxicity
    Lothstein, Leonard
    Savranskaya, Luydmila
    Sweatman, Trevor W.
    [J]. LEUKEMIA RESEARCH, 2007, 31 (08) : 1085 - 1095
  • [5] Critical roles of Noxa and Mcl-1 in the signaling mechanisms of bortezomib in TRAF3-deficient mouse B lymphoma and human multiple myeloma cells
    Luo, Chang
    Han, Yeming
    Liu, Yingying
    Edwards, Shanique K. E.
    Xie, Ping
    [J]. JOURNAL OF IMMUNOLOGY, 2016, 196
  • [6] A Humanized Anti-Ganglioside GM2 Antibody, BIW-8962, Exhibits ADCC/CDC Activity against Multiple Myeloma Cells and Potent Anti-Tumor Activity in Mouse Xenograft Models
    Ishi, Toshihiko
    Chanan-Khan, Asher Alban
    Jafferjee, Jazur
    Ersing, Noreen
    Takahashi, Takeshi
    Mizutani, Masato
    Shiotsu, Yukimasa
    Hanai, Nobuo
    [J]. BLOOD, 2008, 112 (11) : 605 - 605
  • [7] Amdizalisib (HMPL-689), a highly selective PI3Kd inhibitor, exhibits potent anti-tumor activity in pre-clinical B-cell lymphoma models
    Hu, Jia
    Wang, Jianhan
    Dai, Xiaoming
    He, Jianlin
    Liang, Junqing
    Yu, Ying
    Yu, Juntao
    Yang, Na
    Wang, Linfang
    Cai, Yu
    Li, Xiong
    Qing, Weiguo
    Ren, Yongxin
    Su, Weiguo
    [J]. CANCER RESEARCH, 2022, 82 (12)
1